Home › Funds › Nykredit A/S › GILD

Nykredit A/S position in GILD

Gilead Sciences Inc · Health Care

Nykredit A/S reported holding 1,099,728 shares of GILD (Gilead Sciences Inc) in its Q3 2026 13F filing — a position valued at US$163.9M, representing 0.60% of its reported portfolio and ranking #28 among its reported holdings. Nykredit A/S has disclosed GILD holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)1.10M sh
Reported value held$163.91M
Portfolio Weight0.60%
First reportedQ2 2026
Last changeReduce
Updated2026-11-06

Last updated: 2026-11-06 · Source: SEC EDGAR Form 13F-HR

How Nykredit A/S's GILD position evolved

Nykredit A/S first disclosed a stake in GILD in Q2 2026 at 1,112,764 shares (US$140.6M). The position peaked in Q3 2026 at 1,099,728 shares, worth US$163.9M. Across 2 filings, Nykredit A/S increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,099,728 shares valued at US$163.9M — a reduction of -13,036 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 1.11M $140.59M New
Q3 2026 1.10M $163.91M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (Gilead Sciences Inc) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has Nykredit A/S held GILD?

Nykredit A/S has disclosed GILD holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Nykredit A/S's current position in GILD?

As of Q3 2026, Nykredit A/S holds 1.10M shares of GILD (Gilead Sciences Inc), valued at $163.91M, representing 0.60% of its reported portfolio and ranking #28.

Has Nykredit A/S been buying or selling GILD?

In the latest 13F filing (Q3 2026), Nykredit A/S reduced its position in GILD. The position peaked in Q3 2026 at 1.10M shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.